ChordNews
← All news

Amphastar Pharmaceuticals reports non-GAAP EPS of $1.14 and revenue of $207.6M, beating estimates

By ChordNews · First written (updated )

Comments 0

Summary

Amphastar Pharmaceuticals reported non-GAAP earnings per share of $1.14, beating estimates by $0.28, and revenue of $207.6 million, beating estimates by $10.1 million. The source material contains only these headline figures, so no further details of the results are available.

This continues an earlier story: Scotts Miracle-Gro reports non-GAAP EPS of -$2.16, beating estimates by $0.05, while revenue of $302.9M misses by $3.21M

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Amphastar Pharmaceuticals posted non-GAAP EPS of $1.14, beating by $0.28, and revenue of $207.6M, beating by $10.1M.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews